article thumbnail

Where Requests for Discovery were Overly Broad, No Privilege Log was Required

E-Discovery LLC

Because the discovery requests were so “overly broad,” the court held that no privilege log was required on the overbroad requests. KPC Healthcare, Inc., July 17, 2024), the court held that no privilege log was required until scope of discovery objections were resolved. It then specified what must be produced. emphasis added].

Discovery 130
article thumbnail

No Privilege Log Is Needed While Scope of Discovery Objections Are Pending

E-Discovery LLC

KPC Healthcare, Inc., July 17, 2024), the court held that no privilege log was required until scope of discovery objections were resolved. The general rule is that a privilege log is due at the time discovery responses are filed. In Troung v. 2024 WL 3496865 (C.D. Plaintiff Troung alleged ERISA violations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI in Pharmaceuticals: From Discovery to Market

Complex Discovery

Editor’s Note: Artificial intelligence (AI) is transforming the pharmaceutical industry, offering unprecedented opportunities to accelerate drug discovery, streamline clinical trials, and fortify intellectual property (IP) strategies.

article thumbnail

Privilege Log Required of Materials Agency Withheld From Administrative Record

E-Discovery LLC

In Sana Healthcare Carrollton, LLC v. In Sana Healthcare Carrollton, LLC v. Thus, the issue presented in Sana Healthcare was “extra-record discovery” or discovery “beyond the administrative record.”” Id. This blog was initially posted on Electronic Discovery Reference Model. Glock, Inc., 497, 505 (D.

article thumbnail

Five Great Reads on Cyber, Data, and Legal Discovery for July 2024

Complex Discovery

The publication selects five top articles to keep legal, business, and technology professionals informed about key developments in cyber discovery, data discovery, and legal discovery. The disruption led to operational challenges across various sectors, including aviation, finance, and healthcare.

article thumbnail

Artificial Intelligence in Drug Development: Patent Considerations

IP Watchdog

The biopharmaceutical and healthcare fields produce massive amounts of data, including properties and characteristics of drug compounds, biological, genomic, and clinical data, efficacy of treatments, adverse events and risks, and electronic health records. The data may come from many sources, both public and proprietary.

article thumbnail

[Educational Workshop] Practical Insights into Generative AI Workflows for Legal Teams

Complex Discovery

Cohen Partner, Reed Smith, LLP David Cohen is the chair of Reed Smith’s Records & E-Discovery (RED) Group and a member of the Emerging Technologies group. Mack is the author of A Process of Illumination: The Practical Guide to Electronic Discovery , considered by many to be the first popular book on eDiscovery.